NI

NT Investments

Description

NT Investments is an investment firm.

Investor Profile

NT Investments has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NT Investments frequently co-invest with?

LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
Co-Investments: 1
GM
North America, New York, United States, New York
Co-Investments: 1
Bio-Rad Laboratories
North America, California, United States, Hercules
Co-Investments: 1
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 1
LC
North America, Missouri, United States, St Louis
Co-Investments: 1
BioGenerator
North America, Missouri, United States, St Louis
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Innovatus Capital Partners
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by NT Investments?

Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJan 8, 2025
Amount Raised: $105,000,000
Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BNov 16, 2021
Amount Raised: $105,000,000